ReviewCambridge prisms. Extinction2023
Biocultural aspects of species extinctions.
Review in Cambridge prisms. Extinction, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Ecosystem services provided by spiders.Biological reviews of the Cambridge Philosophical Society · 2025Review
- Intergenerational justice, the impending sixth mass extinction, reproduction and advanced biotechnologies, and humanity's future.Cambridge prisms. Extinction · 2025Review
- How is the concept of charisma used in the academic literature about biodiversity conservation? A systematic map protocol.Environmental evidence · 2024Article
- Taxonomies of exclusion: Storytelling, naming and classification in an age of extinction.Cambridge prisms. Extinction · 2024Article
- The diversity of ignorance and the ignorance of diversity: origins and implications of "shadow diversity" for conservation biology and extinction.Cambridge prisms. Extinction · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting whether a species is likely to go extinct (or not) is one of the fundamental objectives of conservation biology, and extinction risk classifications have become an essential tool for conservation policy, planning and research. This sort of prediction is feasible because the extinction processes follow a familiar pattern of population decline, range collapse and fragmentation, and, finally, extirpation of sub-populations through a combination of genetic, demographic and environmental stochasticity. Though less well understood and rarely quantified, the way in which science and society respond to population decline, extirpation and species extinction can also have a profound influence, either negative or positive, on whether a species goes extinct. For example, species that are highly sought after by collectors and hobbyists can become more desirable and valuable as they become rarer, leading to increased demand and greater incentives for illegal trade - known as the anthropogenic Allee effect. Conversely, species that are strongly linked to cultural identity are more likely to benefit from sustainable management, high public support for conservation actions and fund-raising, and, by extension, may be partially safeguarded from extinction. More generally, human responses to impending extinctions are extremely complex, are highly dependent on cultural and socioeconomic context, and have typically been far less studied than the ecological and genetic aspects of extinction. Here, we identify and discuss biocultural aspects of extinction and outline how recent advances in our ability to measure and monitor cultural trends with big data are, despite their intrinsic limitations and biases, providing new opportunities for incorporating biocultural factors into extinction risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.